ECE-1 inhibitors (Hoffmann-La Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameECE-1 inhibitors (Hoffmann-La Roche)
Drug Alias Nameendothelin converting enzyme inhibitors (Hoffmann-La Roche)Ro-0687629Ro-0677447Ro-67-7447Ro-68-7629
ClassificationSmall molecules
Mechanisms of ActionEndothelin-converting enzyme 1 inhibitors
TargetsEndothelin-converting enzyme 1
Therapy Area/IndicationsHypertensionHeart FailureNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionHeart FailureNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A